patrick.net

Pfizer has delayed a major study into the risks of heart damage in children who received the company’s Covid mRNA “vaccines,” pushing the probe back until for another five years.

The delays mean that the results of the study won’t be known until ten years after the injections were first rolled out for public use.

The Pfizer-sponsored clinical trial assessing long-term myocarditis outcomes in youth following Covid mRNA “vaccination” is now expected to be completed by November 2030.

As Slay News has previously reported, Myocarditis is a “silent killer” at the center of the sudden deaths crisis that emerged after the Covid injections were rolled out for public use in early 2021.

Donald Trump:

"I was honored to have Albert [Bourla here]... He's done a fantastic job with...COVID. He did a fantastic job ..."

MONUMENTAL MAHA FAIL: Pfizer Strikes $70 Billion Deal with U.S. to Expand Its mRNA Empire, Lower Drug Prices

‘Landmark agreement’ lets Pfizer expand its disastrous mRNA platform — sweeping a massive trail of death and destruction under the rug.

And just like that the MAHA movement implodes on itself and totally negates today’s earlier winning…

…by unleashing ever more deadly Modified mRNA slow kill bioweapon “vaccines” on the American people with a classic bait-and-switch of cheaper drug prices for the very adverse events that these depopulation injections have already wreaked on society as a whole.

This quid pro quo BigPharma deal is as ugly and dirty as it gets, and RFK Jr. had a difficult time during today’s most unfortunate press conference containing his disgust as Pfizer’s criminally deranged lizard-man CEO Albert Bourla locked in a deal with President Operation Warp Speed:




We need MASS ARRESTS of these BigPharma CEO’s, not scammy ‘TrumpRx’ deals with them.




The message is clear: accountability is off the table, and Pfizer’s genetic empire now stands shielded by the U.S. government itself.

A major new study has found that Pfizer’s popular birth control injection Depo-Provera has triggered surges in deadly and disabling brain tumors among healthy women who received the jab.

The alarming finding confirms long-standing concerns that the pharmaceutical giant allegedly ignored for decades. ...

Their findings were published in JAMA Neurology.

https://jamanetwork.com/journals/jamaneurology/article-abstract/2838202

Depo-Provera has been marketed for decades as a convenient, long-acting contraceptive.

It is used by roughly one in four sexually active American women.

But the study found that risk was particularly high among women who began using the injections after age 31 or stayed on the drug for more than four years.

In addition, a French study published in The British Medical Journal (BMJ) found that women who used Depo-Provera for over a year had a 5.6 times greater risk of developing a meningioma.

Doing the math, that's a 91% payout ratio, which is unsustainable for a pharma.